MedTrace Logo

Facilitated Release of Endogenous Enterokines

NCT04215328 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2020-01-07

No results posted yet for this study

Summary

The overall objective is to develop therapy for obesity and diabetes that is as effective as gastric bypass surgery but without the cost and safety concerns.

Conditions

  • Diabetes Mellitus, Type 2

Interventions

DIETARY_SUPPLEMENT

Mixed-Meal

Per 250ml bottle: 220 calories, protein 9g, carbohydrate 33g (15g sugar), fat 6g, sodium 190mg, potassium 390mg; 500mLs by tube daily in 4 doses

DIETARY_SUPPLEMENT

Electrolyte Solution

Electrolyte Solution 500mLs by tube daily in 4 doses

Sponsors & Collaborators

  • Halyard Health

    collaborator INDUSTRY

  • Wallace H. Coulter Foundation

    collaborator OTHER

  • University of Southern California

    lead OTHER

Principal Investigators

  • Elizabeth Beale, MD · University of Southern California, Keck School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-01
Primary Completion
2019-02-28
Completion
2019-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04215328 on ClinicalTrials.gov